Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation

Targeting tyrosine kinase receptors to tackle CML

Chronic lymphocytic leukaemia: A new treatment era is born

Chemo-free treatment for acute promyelocytic leukaemia

Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels predicting outcomes

NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

BETH study: highly effective treatment option for patients with HER2 breast cancer

Screening mammography, over diagnosis and over treatment

2013 ecancer highlights

2013 ecancermedicalscience article highlights

Initial phase III results of the first trial in newly diagnosed multiple myeloma